Background: Genetic testing is performed for different purposes, such as identifying carriers,
predicting a disease onset in presymptomatic individuals or confirming a diagnosis …

Genetic testing of patients with cancer is increasingly offered to guide management,
resulting in a growing need for oncology health professionals to communicate genetics …

Advances in the application of genomic technologies in clinical care have the potential to
increase existing healthcare disparities. Studies have consistently shown that only a fraction …

For this literature review, medical literature data bases were searched for studies on patient
compliance after genetic risk assessment. The review focused on conditions where …

Background BRCA1/2 testing is crucial to guide clinical decisions in patients with hereditary
breast/ovarian cancer, but detection of variants of uncertain significance (VUSs) prevents …

Background The impact of family and personal cancer history and emotional factors, such as
depression and anxiety, on disease representation has received limited attention in studies …

Background Several studies have shown that counselees do not experience
psychopathological levels of distress after DNA test result disclosure. However, it has not …

In the care of patients with Lynch Syndrome (LS), a range of psychosocial issues are
encountered, which significantly affect patient outcomes. A brief historical background of …

Communicating personalized genomic risk results for common diseases to the general
population as a form of tailored prevention is novel and may require alternative genetic …

In the era of precision medicine, patients must manage the uncertainty caused by
ambiguous genetic information. To aid health practitioners in effectively communicating …